Vividion Therapeutics Funding & Investors
San Diego, CA
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
vividion.comTotal Amount Raised: $371,504,608
Vividion Therapeutics Funding Rounds
Series C
$135,000,000
Series C Investors
Boxer CapitalLogos CapitalArch Venture PartnersBiotechnology Value FundRA Capital ManagementVersant VenturesCasdin CapitalMubadala Capital VenturesDriehaus Capital ManagementNextech InvestSurveyor CapitalT. Rowe PriceAcuta Capital PartnersSVFAvoro Capital AdvisorsWoodline PartnersSeries B
$82,000,000
Series B Investors
Nextech InvestCasdin CapitalTrinitas CapitalAltitude Life Science VenturesMubadala Capital VenturesAlexandriaMirae AssetBiotechnology Value FundVersant VenturesCardinal Health PartnersArch Venture PartnersCelgeneCorporate Round
$101,000,000
Corporate Round Investors
CelgeneSeries A
$50,000,000
Series A Investors
Arch Venture PartnersVersant VenturesCardinal Health PartnersSeries A
$3,504,616
Series A Investors
Cardinal Health Partners
Funding info provided by Diffbot.